CatSci Ltd will be attending the 51st Organic Process Research and Development (OPR&D) conference in San Diego on 12th – 14th March 2024. Dr Jas Douville, our Head of Business Development in North America, and Dr Ivor Smajlagic, our Business Development Manager on the West Coast, will be attending this event.
Hosted by Scientific Update, the OPR&D conference brings together like-minded chemists to collaborate and network with the industry. Jas and Ivor are looking forward to exploring how CatSci can address your CMC challenges with our in-depth drug development expertise. Our capabilities span from preclinical through all phases of development, commercialisation and post approval changes across process chemistry, GMP-analytical, HPAPIs, material sciences and preformulation.
From candidate selection through product launch and beyond, CatSci can de-risk your pharmaceutical pipeline and accelerate your path to clinic. We are your trusted innovation partner for medicines development, and the CatSci team are looking forward to networking with the community and discussing how we can meet your dynamic portfolio demands.
If you would like to book a meeting with Jas and Ivor to discuss how we’ve helped companies with their route scouting, process design & optimisation and scale-up needs, get in touch here.
